Market & RegulationInvestment · $700M
Neko Health raises $700M for US AI body scans
AI Newshigh confidence
Why it matters
- →Neko Health's expansion into the US could set a precedent for AI-driven preventive healthcare services.
- →The significant funding round indicates strong investor confidence in AI's potential to transform medical diagnostics.
- →The integration of AI with traditional medical practices could lead to more comprehensive and efficient health assessments.
Neko Health has raised $700 million in a Series C funding round to expand its AI body scan services in the United States, beginning with a clinic in New York. The round was led by Lightspeed Venture Partners, with participation from notable investors like Mark Zuckerberg and Maria Sharapova. Neko's service combines AI, medical imaging, and blood tests to screen for various health conditions. Despite its rapid growth and 100,000 scans completed, the company has not yet provided peer-reviewed studies validating its approach. The expansion into the US market highlights the increasing interest in AI-driven preventive healthcare.
Read originalThe story around this
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
More in Market & Regulation
Market & Regulationother
Lisbon startup insures AI agents
Insurance for autonomous systems is a nascent market, and this Lisbon startup is positioning itself at the frontier. By targeting liability for AI agents specifically, they address a critical gap as these systems move from experimental to operational in enterprise workflows. This signals that the industry is beginning to treat agent-driven actions with the same risk management rigor as traditional software or human labor. It’s an early bet on the legal and financial infrastructure required for widespread agent adoption.
Sifted
© TechCrunch AIMarket & Regulationother
Anthropic CEO to meet Trump at White House
The meeting between Anthropic's Dario Amodei and President Trump marks a significant pivot in the political landscape of AI safety. Despite recent public clashes over development speed and safety guardrails, this dinner signals a potential thaw in relations that could influence future regulation. The Pentagon's prior designation of Anthropic as a supply-chain risk adds complexity to this engagement. This event underscores how top AI executives are becoming central figures in shaping national policy. The shift from adversarial stances to direct dialogue suggests a new era of industry-government collaboration. Amodei’s presence at the White House elevates the profile of safety concerns in high-level political discourse. This encounter could redefine the boundaries of acceptable AI development under federal oversight.
